Gradiant Corporation Stock

Equities

A035080

KR7035080001

Department Stores

End-of-day quote Korea S.E. 06:00:00 2024-06-06 pm EDT 5-day change 1st Jan Change
16,310 KRW +2.71% Intraday chart for Gradiant Corporation +8.81% +22.36%
Sales 2022 3,585B 2.61B Sales 2023 3,424B 2.49B Capitalization 194B 141M
Net income 2022 327B 238M Net income 2023 -15.84B -11.52M EV / Sales 2022 -0.04 x
Net cash position 2022 358B 260M Net cash position 2023 227B 165M EV / Sales 2023 -0.01 x
P/E ratio 2022
0.7 x
P/E ratio 2023
-11.9 x
Employees -
Yield 2022
1.34%
Yield 2023
1.5%
Free-Float 63.03%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.71%
1 week+8.81%
Current month+8.81%
1 month+2.13%
3 months+1.12%
6 months+44.46%
Current year+22.36%
More quotes
1 week
15 240.00
Extreme 15240
16 770.00
1 month
14 790.00
Extreme 14790
16 770.00
Current year
12 940.00
Extreme 12940
18 900.00
1 year
10 230.00
Extreme 10230
21 450.00
3 years
10 230.00
Extreme 10230
56 500.00
5 years
4 675.00
Extreme 4675
56 500.00
10 years
4 675.00
Extreme 4675
68 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 -
Chief Executive Officer 61 97-09-30
Director of Finance/CFO 57 -
Members of the board TitleAgeSince
Chief Executive Officer 61 97-09-30
President 57 -
Director/Board Member 57 -
More insiders
Date Price Change Volume
24-06-07 16,310 +2.71% 166,615
24-06-05 15,880 +1.40% 31,755
24-06-04 15,660 +2.82% 51,361
24-06-03 15,230 +1.60% 64,670

End-of-day quote Korea S.E., June 06, 2024

More quotes
Gradiant Corp, formerly Interpark Corp, is a Korea-based company mainly engaged in the e-commerce business. The Company operates its business through four segments. The E-commerce Business segment sells products such as fashion, beauty, home decor, and furniture, medical supplies and office supplies through online shopping mall. The E-commerce Related Business segment is engaged in the performance hall operation business, education and training businesses, and rental car businesses. The Bio Health Care Business segment is engaged in the development, research and distribution of pharmaceuticals and medical supplies. The Holding Business segment is engaged in the provision of support and management activities for subsidiaries and affiliated enterprises.
More about the company
  1. Stock Market
  2. Equities
  3. A035080 Stock